SENS
Senseonics Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.72
−1.82%1
Insider buys (3m)
0
Insider sells (3m)
$125.3K
Net value (3m)
+47.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 20, 2026 | ROEDER DOUGLAS A · director | Purchase | 13,953 | $8.98 |
| Jul 2, 2026 | Steven Edelman · director | A-Award | 2,402 | $5.36 |
| Jul 2, 2026 | ROEDER DOUGLAS A · director | A-Award | 2,751 | $5.36 |
| Jul 2, 2026 | Fiorentino Edward · director | A-Award | 2,635 | $5.36 |
| Jul 2, 2026 | Prince Douglas S · director | A-Award | 1,515 | $5.36 |
| Jun 17, 2026 | JAIN Mukul · officer: Chief Operating Officer | F-InKind | 16,194 | $7.18 |
| Jun 17, 2026 | Sullivan Frederick T. · officer: Chief Financial Officer | F-InKind | 5,397 | $7.18 |
| Jun 17, 2026 | Kaufman Francine · director, officer: Chief Medical Officer | F-InKind | 4,010 | $7.18 |
| Jun 17, 2026 | Horton Kenneth L · officer: GC & Corp. Development Advisor | F-InKind | 9,545 | $7.18 |
| Jun 17, 2026 | Goodnow Timothy T · director, officer: President and CEO | F-InKind | 32,598 | $7.18 |
| Jun 17, 2026 | HANSEN BRIAN B · director, officer: Chief Commercial Officer | F-InKind | 5,420 | $7.18 |
| May 21, 2026 | ROEDER DOUGLAS A · director | A-Award | 9,852 | $0.00 |
| May 21, 2026 | Sullivan Frederick T. · officer: Chief Financial Officer | A-Award | 90,253 | $0.00 |
| May 21, 2026 | Fiorentino Edward · director | A-Award | 13,574 | $5.71 |
| May 21, 2026 | Prince Douglas S · director | A-Award | 9,852 | $0.00 |
| May 21, 2026 | Horton Kenneth L · officer: GC & Corp. Development Advisor | A-Award | 157,943 | $0.00 |
| May 21, 2026 | Larkin Sharon · director | A-Award | 13,574 | $5.71 |
| May 21, 2026 | Steven Edelman · director | A-Award | 13,574 | $5.71 |
| May 21, 2026 | Sullivan Frederick T. · officer: Chief Financial Officer | A-Award | 124,193 | $5.54 |
| May 21, 2026 | JAIN Mukul · officer: Chief Operating Officer | A-Award | 372,579 | $5.54 |
| May 21, 2026 | Larkin Sharon · director | A-Award | 9,852 | $0.00 |
| May 21, 2026 | Kaufman Francine · director, officer: Chief Medical Officer | A-Award | 63,177 | $0.00 |
| May 21, 2026 | Goodnow Timothy T · director, officer: President and CEO | A-Award | 553,701 | $0.00 |
| May 21, 2026 | Goodnow Timothy T · director, officer: President and CEO | A-Award | 761,923 | $5.54 |
| May 21, 2026 | HANSEN BRIAN B · director, officer: Chief Commercial Officer | A-Award | 124,193 | $5.54 |
| May 21, 2026 | JAIN Mukul · officer: Chief Operating Officer | A-Award | 270,759 | $0.00 |
| May 21, 2026 | DeFalco Stephen P · director | A-Award | 9,852 | $0.00 |
| May 21, 2026 | DeFalco Stephen P · director | A-Award | 13,574 | $5.71 |
| May 21, 2026 | Fiorentino Edward · director | A-Award | 9,852 | $0.00 |
| May 21, 2026 | Kaufman Francine · director, officer: Chief Medical Officer | A-Award | 86,935 | $5.54 |
Institutional positioning
13F filings over the trailing two quarters
New 26Increased 17Reduced 24Sold out 85
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SESSA CAPITAL IM, L.P. | New Position | 1,766,093 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,617,197 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 568,729 | May 13, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 560,371 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 525,538 | May 15, 2026 |
| MASTERS CAPITAL MANAGEMENT LLC | Increased | 500,000 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 466,515 | May 15, 2026 |
| MARSHALL WACE, LLP | Increased | 464,375 | May 15, 2026 |
| UBS GROUP AG | Increased | 448,229 | May 5, 2026 |
| GOLDMAN SACHS GROUP INC | New Position | 327,618 | Mar 25, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 225,167 | May 8, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Increased | 221,177 | May 15, 2026 |
| HOOD RIVER CAPITAL MANAGEMENT LLC | Reduced | 186,426 | May 15, 2026 |
| STATE STREET CORP | Increased | 180,281 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 146,282 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 20, 2026